Search
for

    Glossary Troglitazone

    medication for type 2 diabetes, withdrawn due to liver toxicity

    Troglitazone, also known as Rezulin, is a medication that was used to treat type 2 diabetes by improving insulin sensitivity. However, it was withdrawn from the market due to severe liver toxicity and associated health risks.

    Research 5 of 123

    1. Treatment of Lipodystrophy with Troglitazone Annals of Internal Medicine · 2001 · 1 citations
    2. Obesity and polycystic ovary syndrome Clinical Endocrinology · 2021 · 90 citations
    3. INSULIN-LOWERING MEDICATIONS IN POLYCYSTIC OVARY SYNDROME Obstetrics and Gynecology Clinics of North America · 2000 · 39 citations
    4. Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome Endocrine Practice · 2001 · 32 citations
    5. Insulin Resistance and Polycystic Ovary Syndrome John Wiley & Sons, Ltd eBooks · 2004
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →